BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. T cell differentiation, Obesity, Lung, Autoimmunity, Lovastatin, rs4950928, ERBB2)
Bookmark Forward

QuickView for lovastatin (compound)


Genetic Markers

Most Correlated Genes

  1. HMGCR
  2. Acot1
  3. STAC3
  4. NFE2
  5. EHHADH
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. response to organic substance
  2. organic cyclic compound binding
  3. heterocyclic compound binding
  4. organic cyclic compound metabolic process
  5. cell differentiation
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Diverse liver drug signatures
  2. Identification of biomarkers distinguishing chemical contaminants using rat hepatocytes
  3. Genomics Assisted Toxicity Evaluation system study - Human Hepatocytes
  4. Genomics Assisted Toxicity Evaluation system study - Rat Liver Single Dose
  5. Genomics Assisted Toxicity Evaluation system study - Rat Liver Repeat Doses
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Structural basis for the biosynthesis of lovastatin.
  2. Characterization of chitosan/alginate/lovastatin nanoparticles and investigation of their toxic effe…
  3. Environmental cues that induce the physiology of solid medium: a study on lovastatin production by A…
  4. Lovastatin, not Simvastatin, Corrects Core Phenotypes in the Fragile X Mouse Model.
  5. Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Pre-Prostatectomy Lovastatin on Prostate Cancer
  2. Lovastatin for Treatment of Brain Arteriovenous Malformations
  3. Lovastatin: Immunomodulatory Value Evaluation
  4. Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention
  5. Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma
Explore Clinical Trials Results
  • Copyright © 2021 Illumina Inc. All rights reserved.